CacheBy
Thermo Fisher Scientific Human PHLPP1 Synthetic Peptide
원본

Thermo Fisher Scientific Human PHLPP1 Synthetic Peptide

상품 한눈에 보기

인간 PHLPP1의 아미노 말단 18개 아미노산 서열 기반 합성 펩타이드. 항체 PA5-34434의 블로킹 펩타이드로 사용 가능. 액상 형태, 200 µg/mL 농도, PBS(pH 7.2) + 0.1% BSA + 0.02% sodium azide 저장. 연구용으로만 사용.

카탈로그번호
PEP1476
카테고리
Protein
판매단위
pk
카탈로그 보기

카탈로그

1개 옵션
회원가입 없이 바로 구매하세요
가입하지 않아도 비회원가로 구매하실 수 있습니다.
마지막 업데이트 2025. 08. 05. 오전 03:14
Thermo Fisher Scientific PEP1476 Human PHLPP1 Synthetic Peptide 50 ug pk판매 단위 pk ·
재고 확인 필요
195,500원VAT 포함 215,050원

Thermo Fisher Scientific · Thermo Fisher Scientific Human PHLPP1 Synthetic Peptide

Applications

Control (Ctrl)

  • Assay-dependent

Blocking Assay (BLOCK)

  • Assay-dependent

Product Specifications

항목 내용
Species Reactivity Human
Class Synthetic
Type Peptide
Conjugate Unconjugated
Form Liquid
Concentration 200 µg/mL
Purification Purified
Storage Buffer PBS, pH 7.2, with 0.1% BSA
Contains 0.02% sodium azide
Storage Conditions -20°C

Product Specific Information

This peptide corresponds to an 18 amino acid sequence near the amino terminus of human PHLPP1.
PEP-1476 can be used as a blocking peptide with polyclonal antibody PA5-34434.

Target Information

PHLPP1 is a member of the serine/threonine phosphatase family, which are important regulators of Akt serine-threonine kinases (AKT1, AKT2, AKT3) and conventional/novel protein kinase C (PKC) isoforms.
PHLPP1 and PHLPP2 have similar domain structures and have been shown to dephosphorylate and inactivate distinct Akt isoforms at one of the two critical phosphorylation sites required for activation (Serine473).
PHLPP2 dephosphorylates AKT1 and AKT3, whereas PHLPP1 is specific for AKT2 and AKT3.
PHLPP1 promotes apoptosis and may act as a tumor suppressor. Increased expression of PHLPP1 may also play a role in obesity and type 2 diabetes by interfering with Akt-mediated insulin signaling.

For Research Use Only.
Not for use in diagnostic procedures.
Not for resale without express authorization.

Thermo Fisher Scientific 상품 둘러보기

전체보기

문의

0

아직 등록된 문의가 없어요.